1
|
Greenstein AS, Kadir SZAS, Csato V, Sugden SA, Baylie RA, Eisner DA, Nelson MT. Disruption of Pressure-Induced Ca 2+ Spark Vasoregulation of Resistance Arteries, Rather Than Endothelial Dysfunction, Underlies Obesity-Related Hypertension. Hypertension 2019; 75:539-548. [PMID: 31865779 PMCID: PMC7055934 DOI: 10.1161/hypertensionaha.119.13540] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
Supplemental Digital Content is available in the text. Obesity-related hypertension is one of the world’s leading causes of death and yet little is understood as to how it develops. As a result, effective targeted therapies are lacking and pharmacological treatment is unfocused. To investigate underlying microvascular mechanisms, we studied small artery dysfunction in a high fat–fed mouse model of obesity. Pressure-induced constriction and responses to endothelial and vascular smooth muscle agonists were studied using myography; the corresponding intracellular Ca2+ signaling pathways were examined using confocal microscopy. Principally, we observed that the enhanced basal tone of mesenteric resistance arteries was due to failure of intraluminal pressure-induced Ca2+ spark activation of the large conductance Ca2+ activated K+ potassium channel (BK) within vascular smooth muscle cells. Specifically, the uncoupling site of this mechanotransduction pathway was at the sarcoplasmic reticulum, distal to intraluminal pressure-induced oxidation of Protein Kinase G. In contrast, the vasodilatory function of the endothelium and the underlying endothelial IP-3 and TRPV4 (vanilloid 4 transient receptor potential ion channel) Ca2+ signaling pathways were not affected by the high-fat diet or the elevated blood pressure. There were no structural alterations of the arterial wall. Our work emphasizes the importance of the intricate cellular pathway by which intraluminal pressure maintains Ca2+ spark vasoregulation in the origin of obesity-related hypertension and suggests previously unsuspected avenues for pharmacological intervention.
Collapse
Affiliation(s)
- Adam S Greenstein
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| | | | - Viktoria Csato
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| | - Sarah A Sugden
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| | - Rachael A Baylie
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| | - David A Eisner
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| | - Mark T Nelson
- From the Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, United Kingdom
| |
Collapse
|
2
|
Csato V, Kadir SZSA, Khavandi K, Bennett H, Sugden S, Gurney AM, Pritchard HT, Hill‐Eubanks D, Eaton P, Nelson MT, Greenstein AS. "A Step and a Ceiling": mechanical properties of Ca 2+ spark vasoregulation in resistance arteries by pressure-induced oxidative activation of PKG. Physiol Rep 2019; 7:e14260. [PMID: 31782255 PMCID: PMC6883097 DOI: 10.14814/phy2.14260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 07/26/2019] [Accepted: 07/27/2019] [Indexed: 11/24/2022] Open
Abstract
We investigated the biomechanical relationship between intraluminal pressure within small mesenteric resistance arteries, oxidant activation of PKG, Ca2+ sparks, and BK channel vasoregulation. Mesenteric resistance arteries from wild type (WT) and genetically modified mice with PKG resistance to oxidative activation were studied using wire and pressure myography. Ca2+ sparks and Ca2+ transients within vascular smooth muscle cells of intact arteries were characterized using high-speed confocal microscopy of intact arteries. Arteries were studied under conditions of varying intraluminal pressure and oxidation. Intraluminal pressure specifically, rather than the generic stretch of the artery, was necessary to activate the oxidative pathway. We demonstrated a graded step activation profile for the generation of Ca2+ sparks and also a functional "ceiling" for this pressure --sensitive oxidative pathway. During steady state pressure - induced constriction, any additional Ca2+ sensitive-K+ channel functional availability was independent of oxidant activated PKG. There was an increase in the amplitude, but not the Area under the Curve (AUC) of the caffeine-induced Ca2+ transient in pressurized arteries from mice with oxidant-resistant PKG compared with wild type. Overall, we surmise that intraluminal pressure within resistance arteries controls Ca2+ spark vasoregulation through a tightly controlled pathway with a graded onset switch. The pathway, underpinned by oxidant activation of PKG, cannot be further boosted by additional pressure or oxidation once active. We propose that these restrictive characteristics of pressure-induced Ca2+ spark vasoregulation confer stability for the artery in order to provide a constant flow independent of additional pressure fluctuations or exogenous oxidants.
Collapse
Affiliation(s)
- Viktoria Csato
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
- Division of Clinical PhysiologyInstitute of CardiologyResearch Centre for Molecular MedicineFaculty of MedicineUniversity of DebrecenDebrecenHungary
| | - Sharifah Z. S. A. Kadir
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
- Department of PharmacologyFaculty of MedicineUniversity of MalayaKuala LumpurMalaysia
| | - Kaivan Khavandi
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| | - Hayley Bennett
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| | - Sarah Sugden
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| | - Alison M. Gurney
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| | - Harry T. Pritchard
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| | | | - Philip Eaton
- Centre for Clinical PharmacologyWilliam Harvey Research InstituteQueen Mary University of LondonLondonUnited Kingdom
- Present address:
Centre for Clinical PharmacologyWilliam Harvey Research InstituteQueen Mary University of LondonLondonUnited Kingdom
| | - Mark T. Nelson
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
- Department of PharmacologyUniversity of VermontBurlingtonVermont
| | - Adam S. Greenstein
- Division of Cardiovascular SciencesFaculty of Biology, Medicine and HealthUniversity of ManchesterHealth Innovation Manchester NetworkManchesterUnited Kingdom
| |
Collapse
|
3
|
Khavandi K, Baylie RA, Sugden SA, Ahmed M, Csato V, Eaton P, Hill-Eubanks DC, Bonev AD, Nelson MT, Greenstein AS. Pressure-induced oxidative activation of PKG enables vasoregulation by Ca2+ sparks and BK channels. Sci Signal 2016; 9:ra100. [PMID: 27729550 DOI: 10.1126/scisignal.aaf6625] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Activation of Ca2+-sensitive, large-conductance potassium (BK) channels in vascular smooth muscle cells (VSMCs) by local, ryanodine receptor-mediated Ca2+ signals (Ca2+ sparks) acts as a brake on pressure-induced (myogenic) vasoconstriction-a fundamental mechanism that regulates blood flow in small resistance arteries. We report that physiological intraluminal pressure within resistance arteries activated cGMP-dependent protein kinase (PKG) in VSMCs through oxidant-induced formation of an intermolecular disulfide bond between cysteine residues. Oxidant-activated PKG was required to trigger Ca2+ sparks, BK channel activity, and vasodilation in response to pressure. VSMCs from arteries from mice expressing a form of PKG that could not be activated by oxidants showed reduced Ca2+ spark frequency, and arterial preparations from these mice had decreased pressure-induced activation of BK channels. Thus, the absence of oxidative activation of PKG disabled the BK channel-mediated negative feedback regulation of vasoconstriction. Our results support the concept of a negative feedback control mechanism that regulates arterial diameter through mechanosensitive production of oxidants to activate PKG and enhance Ca2+ sparks.
Collapse
Affiliation(s)
- Kaivan Khavandi
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK.,King's College London, Cardiovascular Division, The British Heart Foundation Centre of Excellence, The Rayne Institute, Saint Thomas' Hospital, London, SE1 7EH, UK
| | - Rachael A Baylie
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK
| | - Sarah A Sugden
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK
| | - Majid Ahmed
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK.,Department of Pharmacology, University of Vermont, Vermont, 05405-0068, USA
| | - Viktoria Csato
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK.,Division of Clinical Physiology, Institute of Cardiology, Research Centre for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen 4012, Hungary
| | - Philip Eaton
- King's College London, Cardiovascular Division, The British Heart Foundation Centre of Excellence, The Rayne Institute, Saint Thomas' Hospital, London, SE1 7EH, UK
| | | | - Adrian D Bonev
- Department of Pharmacology, University of Vermont, Vermont, 05405-0068, USA
| | - Mark T Nelson
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK.,Department of Pharmacology, University of Vermont, Vermont, 05405-0068, USA
| | - Adam S Greenstein
- Institute of Cardiovascular Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Sciences Center, Manchester, M13 9NT, UK
| |
Collapse
|